Hướng dẫn khẩn cấp cho chẩn đoán và điều trị viêm phổi nhiễm virus corona mới (2019-nCoV) (phiên bản chuẩn)

Springer Science and Business Media LLC - 2020
Yinghui Jin1, Lin Cai2, Zhenshun Cheng3, Hong Cheng4, Tao Deng1,5, Yipin Fan6,7, Cheng Fang1, Di Huang1, Luqi Huang7,6, Qiao Huang1, Yong Han2, Bo Hu8, Fen Hu8, Binghui Li5,1, Yirong Li9, Ke Liang10, Likai Lin2, Lisha Luo1, Jing Ma8, Linlu Ma1, Zhiyong Peng8, Yunbao Pan9, Zhenyu Pan11, Xuequn Ren5, Hongchun Sun12, Ying Wang13, Xinghuan Wang1, Hong Weng1, Chaojie Wei3, Dongde Wu4, Jian Chuan Xia14, Yong Xiong10, Haibo Xu15, Xiaomei Yao16, Yuan Yua2, Taisheng Ye17, Xiaochun Zhang15, Ying‐Wen Zhang17, Yin-Gao Zhang2, Huamin Zhang7,6, Yan Zhao14, Ming-Juan Zhao1, Hao Zi5,1, Xian‐Tao Zeng18,1, Yongyan Wang7,6
1Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
2Institute of Hospital Management, Wuhan University, Wuhan, China
3Department of Respiratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
4Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, China
5Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China
6China Academy of Chinese Medical Sciences, Beijing, China
7China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM), Beijing, China
8Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
9Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China
10Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China
11Division of Medical Affairs, Zhongnan Hospital of Wuhan University, Wuhan, China
12Division of Nursing Affairs, Zhongnan Hospital of Wuhan University, Wuhan, China
13Office of Nosocomial Infection Control, Zhongnan Hospital of Wuhan University, Wuhan, China
14Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, China
15Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China
16Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
17Department of Traditional Chinese Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
18Global Health Institute, Wuhan University, Wuhan, China

Tóm tắt

Tóm tắt

Vào tháng 12 năm 2019, một loại viêm phổi do virus mới đã được phát hiện ở Vũ Hán, tỉnh Hồ Bắc; và sau đó được Tổ chức Y tế Thế giới (WHO) đặt tên là "virus corona mới (2019-nCoV)" vào ngày 12 tháng 1 năm 2020. Do đây là một loại bệnh hô hấp chưa từng trải qua trước đây với khả năng lây nhiễm rộng rãi và nhanh chóng, nó đã thu hút sự chú ý của thế giới nhưng không có phương pháp điều trị và hướng dẫn kiểm soát nào. Nhằm đáp ứng yêu cầu từ các bác sĩ và cán bộ y tế công cộng về quản lý viêm phổi do 2019-nCoV, một hướng dẫn dựa trên chứng cứ cần thiết phải được phát triển một cách khẩn cấp. Do đó, chúng tôi đã soạn thảo hướng dẫn này theo phương pháp hướng dẫn nhanh và các quy định chung về phát triển hướng dẫn của WHO; chúng tôi cũng đã bổ sung dữ liệu quản lý thực tế từ Bệnh viện Trung Nam của Đại học Vũ Hán. Hướng dẫn này bao gồm phương pháp hướng dẫn, đặc điểm dịch tễ học, sàng lọc bệnh và phòng ngừa cộng đồng, chẩn đoán, điều trị và kiểm soát (bao gồm cả Y học cổ truyền Trung Quốc), phòng ngừa và kiểm soát nhiễm khuẩn bệnh viện, và điều dưỡng bệnh tật liên quan đến 2019-nCoV. Hơn nữa, chúng tôi cũng cung cấp một quy trình toàn diện về một trường hợp điều trị thành công viêm phổi nặng do nhiễm 2019-nCoV và những kinh nghiệm cũng như bài học trong việc cứu chữa tại bệnh viện đối với các ca nhiễm 2019-nCoV. Hướng dẫn khẩn cấp này phù hợp cho các bác sĩ và y tá tuyến đầu, các nhà quản lý bệnh viện và lĩnh vực y tế, cư dân cộng đồng, nhân viên y tế công cộng, các nhà nghiên cứu liên quan, và tất cả những người quan tâm đến 2019-nCoV.

Từ khóa


Tài liệu tham khảo

World Health Organization. WHO handbook for guideline development. 2nd ed; 2019. http://apps.who.int/medicinedocs/documents/s22083en/s22083en.pdf. Accessed 22 Jan 2020

Norris SL. WHO and rapid advice guidelines: history and future directions. 2013. https://g-i-n.net/conference/past-conferences/10th-conference/monday/10-00-am-to-1-00-pm/norris-62.pdf/view. Accessed 22 Jan 2020.

Schünemann HJ, Zhang Y, Oxman AD, Expert Evidence in Guidelines Group. Distinguishing opinion from evidence in guidelines. BMJ. 2019;366:l4606.

GRADE handbook, GRADE working group. 2013. https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 22 Jan 2020.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.

Legault K, Schunemann H, Hillis C, et al. McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. J Thromb Haemost. 2018;16:1656–64.

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). Yixue Xinzhi. 2020;30(1):35–64. https://doi.org/10.12173/j.issn.1004-5511.2020.01.09 [Article in China].

Chan JFW, Yuan S, Kok KH, To KKT, Chu HC, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30154-9.

Health Emergency Office of National Health Commission of the PRC. Update on the epidemic of novel coronavirus (2019-nCoV) infected pneumonia as at 24:00 on 26 January. http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml. Accessed 26 Jan 2020.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. https://doi.org/10.1038/s41586-020-2012-7.

Perlman S. Another decade, another coronavirus. N Engl J Med. 2020. https://doi.org/10.1056/NEJMe2001126.

General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 4). 2020. http://bgs.satcm.gov.cn/zhengcewenjian/2020-01-28/12576.html. Accessed 29 Jan 2020.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001017.

General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 3). 2020. http://www.nhc.gov.cn/xcs/zhengcwj/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml. Accessed 24 Jan 2020.

Information Office of the State Council. Information office to hold press conference on joint preventing and controlling the epidemic of novel coronavirus (2019-nCoV) infected pneumonia. 2020. http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42478/index.htm. Accessed 26 Jan 2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30183-5.

Li L, Ren MJ, Zhang YY, Li WQ, Zhao HY, Liang LC, et al. Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS). Yixue Xinzhi. 2020;30(1):4–6 [Article in China].

Disease Control and Prevention Bureau of National Health and Health Commission. Program for prevention and control of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 2). 2020. http://www.nhc.gov.cn/xcs/zhengcwj/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml. Accessed 23 Jan 2020.

World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. 2020. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts. Accessed 24 Jan 2020.

Kim JY, Song JY, Yoon YK, Choi SH, Song YG, Kim SR, et al. Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother. 2015;47(4):278–302.

Wang Y, Lin LK. An advice guideline recommended by central south hospital for the suspected patients of novel coronavirus (2019-nCoV) infected pneumonia and their close contactsas at home quarantine. 2020. https://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2w. Accessed 25 Jan 2020.

World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. 2020. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125. Accessed 26 Jan 2020.

World Health Organization. WHO advice for international travel and trade in relation to the outbreak of pneumonia caused by a new coronavirus in China. 2020. https://www.who.int/ith/2020-0901_outbreak_of_Pneumonia_caused_by_a_new_coronavirus_in_C/en/. Accessed 23 Jan 2020.

Centers for Disease Control and Prevention. CDC: travelers’ health - novel coronavirus in China. 2020. https://wwwnc.cdc.gov/travel/notices/watch/novel-coronavirus-china. Accessed 23 Jan 2020.

Wang W, Hu H, Song L, Gong X, Qu Y, Lu Z. Image of pulmonary and diagnosis of atypicalnovel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients. Yixue Xinzhi. 2020;30(1):7–9 [Article in China].

Chan KS, Lai ST, Chu CM, Tsui E, Tam CY, Wong MM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003;9(6):399–406.

Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–6.

Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24(9):583–91.

Brigitte M, Arti B, Stephan A, Judith A, Bruno R, Christoph W, et al. MERS-COV disease associated ARDS -a case report. Crit Care Med. 2015;43(12):308.

Jiang H, Deng H, Wang Y, Liu Z, Sun WM. The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies. Zhonghua Jizhen Yixue Zazhi. 2020;29(2):182–6 [Article in China].

Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, et al. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013;19(10):1313–7.

Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015;212(12):1904–13.

Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14(11):1090–5.

Khan PA, Nousheen BB, Maryam N, Sultana K. Middle east respiratory syndrome (MERS): a systematic review. Int J Pharm Sci Res. 2018;9(7):2616–25.

Zhao ZW, Zhang FC, Xu M, Huang K, Zhong WN, Cai WP, et al. Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003. Zhonghua Yixue Zazhi. 2003;83(9):713–8.

Meng QH, Dong PL, Guo YB, Zhang K, Liang LC, Hou W, et al. Use of glucocorticoid in treatment of severe acute respiratory syndrome cases. Zhonghua Yufang Yixue Zazhi. 2003;37(4):233–5 [Article in China].

Xiao JZ, Ma L, Gao J, Yang ZJ, Xing XY, Zhao HC, et al. Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Neike Zazhi. 2004;43(3):179–82 [Article in China].

ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả